F.D. Tattersall

2.6k total citations
30 papers, 2.0k citations indexed

About

F.D. Tattersall is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Surgery. According to data from OpenAlex, F.D. Tattersall has authored 30 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Cellular and Molecular Neuroscience, 13 papers in Molecular Biology and 12 papers in Surgery. Recurrent topics in F.D. Tattersall's work include Nausea and vomiting management (11 papers), Neuropeptides and Animal Physiology (10 papers) and Anesthesia and Pain Management (7 papers). F.D. Tattersall is often cited by papers focused on Nausea and vomiting management (11 papers), Neuropeptides and Animal Physiology (10 papers) and Anesthesia and Pain Management (7 papers). F.D. Tattersall collaborates with scholars based in United Kingdom, United States and Canada. F.D. Tattersall's co-authors include Richard Hargreaves, Wayne Rycroft, R.J. Naylor, R.G. Hill, B. Costall, A.M. Domeney, Margaret A. Cascieri, Annette Robichaud, Hedaythul Choudhury and D. Euan MacIntyre and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and British Journal of Pharmacology.

In The Last Decade

F.D. Tattersall

30 papers receiving 1.9k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
F.D. Tattersall 802 774 725 415 204 30 2.0k
K T Bunce 769 1.0× 725 0.9× 549 0.8× 362 0.9× 186 0.9× 45 1.9k
Wayne Rycroft 779 1.0× 605 0.8× 404 0.6× 273 0.7× 211 1.0× 21 1.5k
Lakhbir Singh 705 0.9× 612 0.8× 251 0.3× 814 2.0× 171 0.8× 38 1.6k
Theodore C. Spaulding 507 0.6× 349 0.5× 256 0.4× 479 1.2× 159 0.8× 41 1.2k
Nirmala Suman‐Chauhan 909 1.1× 816 1.1× 161 0.2× 420 1.0× 208 1.0× 39 1.7k
Pao‐Luh Tao 1.4k 1.7× 896 1.2× 179 0.2× 842 2.0× 134 0.7× 105 2.3k
N S Gee 1.1k 1.4× 1.2k 1.5× 282 0.4× 906 2.2× 76 0.4× 29 2.7k
T. Meert 723 0.9× 445 0.6× 159 0.2× 462 1.1× 98 0.5× 44 1.7k
Michael B. Tyers 977 1.2× 716 0.9× 164 0.2× 375 0.9× 134 0.7× 24 1.5k
Ti‐Zhi Su 711 0.9× 809 1.0× 154 0.2× 703 1.7× 65 0.3× 22 1.9k

Countries citing papers authored by F.D. Tattersall

Since Specialization
Citations

This map shows the geographic impact of F.D. Tattersall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F.D. Tattersall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F.D. Tattersall more than expected).

Fields of papers citing papers by F.D. Tattersall

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F.D. Tattersall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F.D. Tattersall. The network helps show where F.D. Tattersall may publish in the future.

Co-authorship network of co-authors of F.D. Tattersall

This figure shows the co-authorship network connecting the top 25 collaborators of F.D. Tattersall. A scholar is included among the top collaborators of F.D. Tattersall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F.D. Tattersall. F.D. Tattersall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Morriello, Gregori J., Sander G. Mills, Mikhail Reibarkh, et al.. (2010). Substituted fused bicyclic pyrrolizinones as potent, orally bioavailable hNK1 antagonists. Bioorganic & Medicinal Chemistry Letters. 20(6). 2007–2012. 8 indexed citations
2.
McDonald, Louise, et al.. (2008). Discriminative stimulus effects of tiagabine and related GABAergic drugs in rats. Psychopharmacology. 197(4). 591–600. 13 indexed citations
3.
Li, Jennifer, R.L. Fish, Susan M. Cook, F.D. Tattersall, & John Atack. (2006). Comparison of in vivo and ex vivo [3H]flumazenil binding assays to determine occupancy at the benzodiazepine binding site of rat brain GABAA receptors. Neuropharmacology. 51(1). 168–172. 29 indexed citations
4.
McDonald, Louise, et al.. (2006). Gaboxadol, a selective extrasynaptic GABAA agonist, does not generalise to other sleep-enhancing drugs: A rat drug discrimination study. Neuropharmacology. 52(3). 844–853. 6 indexed citations
5.
Dawson, Gerard R., Karen Maubach, Neil Collinson, et al.. (2006). An Inverse Agonist Selective for α5 Subunit-Containing GABAA Receptors Enhances Cognition. Journal of Pharmacology and Experimental Therapeutics. 316(3). 1335–1345. 207 indexed citations
6.
Guest, Paul C., Heather A. Skynner, Kamran Salim, et al.. (2005). Detection of gender differences in rat lens proteins using 2‐D‐DIGE. PROTEOMICS. 6(2). 667–676. 11 indexed citations
7.
Hollingworth, Gregory J., Emma Carlson, José L. Castro, et al.. (2005). Novel lactam NK1 antagonists with anti-emetic activity. Bioorganic & Medicinal Chemistry Letters. 16(5). 1197–1201. 1 indexed citations
8.
Sternfeld, Francine, Robert W. Carling, Richard A. Jelley, et al.. (2004). Selective, Orally Active γ-Aminobutyric Acid A α5 Receptor Inverse Agonists as Cognition Enhancers. Journal of Medicinal Chemistry. 47(9). 2176–2179. 92 indexed citations
9.
Hesketh, Paul J., Simon Van Belle, Matti Aapro, et al.. (2003). Differential involvement of neurotransmitters through the time course of cisplatin-induced emesis as revealed by therapy with specific receptor antagonists. European Journal of Cancer. 39(8). 1074–1080. 208 indexed citations
10.
Huskey, Su-Er W., Brian J. Dean, Ray Bakhtiar, et al.. (2003). BRAIN PENETRATION OF APREPITANT, A SUBSTANCE P RECEPTOR ANTAGONIST, IN FERRETS. Drug Metabolism and Disposition. 31(6). 785–791. 42 indexed citations
11.
Robichaud, Annette, Chantal Savoie, Panagiota B. Stamatiou, F.D. Tattersall, & C C Chan. (2001). PDE4 inhibitors induce emesis in ferrets via a noradrenergic pathway. Neuropharmacology. 40(2). 262–269. 107 indexed citations
12.
Tattersall, F.D., Wayne Rycroft, M. Cumberbatch, et al.. (2000). The novel NK1 receptor antagonist MK–0869 (L–754,030) and its water soluble phosphoryl prodrug, L–758,298, inhibit acute and delayed cisplatin-induced emesis in ferrets. Neuropharmacology. 39(4). 652–663. 120 indexed citations
13.
Robichaud, Annette, F.D. Tattersall, Hedaythul Choudhury, & Ian W. Rodger. (1999). Emesis induced by inhibitors of type IV cyclic nucleotide phosphodiesterase (PDE IV) in the ferret. Neuropharmacology. 38(2). 289–297. 80 indexed citations
14.
Rupniak, N.M.J., F.D. Tattersall, Angela Williams, et al.. (1997). In vitro and in vivo predictors of the anti-emetic activity of tachykinin NK1 receptor antagonists. European Journal of Pharmacology. 326(2-3). 201–209. 88 indexed citations
15.
Tattersall, F.D., Wayne Rycroft, B. Francis, et al.. (1996). Tachykinin NK1 receptor antagonists act centrally to inhibit emesis induced by the chemotherapeutic agent cisplatin in ferrets. Neuropharmacology. 35(8). 1121–1129. 189 indexed citations
16.
17.
Tattersall, F.D., Wayne Rycroft, R.G. Hill, & Richard Hargreaves. (1994). Enantioselective inhibition of ampomorphine-induced emesis in the ferret by the neurokinin1 receptor antagonist CP-99,994. Neuropharmacology. 33(2). 259–260. 75 indexed citations
18.
Tattersall, F.D., Wayne Rycroft, Richard Hargreaves, & R.G. Hill. (1993). The tachykinin NK1 receptor antagonist CP-99,994 attenuates cisplatin induced emesis in the ferret. European Journal of Pharmacology. 250(1). R5–R6. 88 indexed citations
19.
Costall, B., et al.. (1990). Fluphenazine, ICS 205–930 and dl-fenfluramine differentially antagonise drug-induced emesis in the ferret. Neuropharmacology. 29(5). 453–462. 38 indexed citations
20.
Dourish, Colin T., A Rückert, F.D. Tattersall, & S.D. Iversen. (1989). Evidence that decreased feeding induced by systemic injection of cholecystokinin is mediated by CCK-A receptors. European Journal of Pharmacology. 173(2-3). 233–234. 101 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by K T Bunce Breakdown of academic impact, for papers by Wayne Rycroft Breakdown of academic impact, for papers by Lakhbir Singh Breakdown of academic impact, for papers by Theodore C. Spaulding Breakdown of academic impact, for papers by Nirmala Suman‐Chauhan Breakdown of academic impact, for papers by Pao‐Luh Tao Breakdown of academic impact, for papers by N S Gee Breakdown of academic impact, for papers by T. Meert Breakdown of academic impact, for papers by Michael B. Tyers Breakdown of academic impact, for papers by Ti‐Zhi Su
Rankless by CCL
2026